The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation
Open accessThe DOI matches its Crossref record; 172 of the 176 references it cites were found in a registry or an index.
Abstract
The NLRP3 inflammasome is a critical component of the innate immune system that mediates caspase-1 activation and the secretion of proinflammatory cytokines IL-1β/IL-18 in response to microbial infection and cellular damage. However, the aberrant activation of the NLRP3 inflammasome has been linked with several inflammatory disorders, which include cryopyrin-associated periodic syndromes, Alzheimer’s disease, diabetes, and atherosclerosis. The NLRP3 inflammasome is activated by diverse stimuli, and multiple molecular and cellular events, including ionic flux, mitochondrial dysfunction, and the production of reactive oxygen species, and lysosomal damage have been shown to trigger its activation. How NLRP3 responds to those signaling events and initiates the assembly of the NLRP3 inflammasome is not fully understood. In this review, we summarize our current understanding of the mechanisms of NLRP3 inflammasome activation by multiple signaling events, and its regulation by post-translational modifications and interacting partners of NLRP3.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Many molecules or cellular events, including ROS, ionic flux, mitochondrial dysfunction and lysosomal damage, have also been shown to activate NLRP3350 (Fig. 6).”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [350]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Moon, J.-S., Nakahira, K., Chung, K.-P., DeNicola, G. M., Koo, M. J., Pabón, M. A., Rooney, K. T., Yoon, J.-H., Ryter, S. W., Stout-Delgado, H., et al. (2016) · Nature Medicine · doi:10.1038/nm.4153 · Cited by 291 · cited 1×
“Furthermore, NADPH oxidase 4 (NOX4) was shown to regulate carnitine palmitoyltransferase 1A (CPT1A) and cause increased fatty acid oxidation, which contributes to NLRP3 inflammasome activation [96].”
BackgroundRetractedCalcium's Role in Mechanotransduction during Muscle Development
Benavides Damm, T., & Egli, M. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000356667 · Cited by 14,502
Pattern Recognition Receptors and Inflammation
Takeuchi, O., & Akira, S. (2010) · Cell · doi:10.1016/j.cell.2010.01.022 · Cited by 8,895 · cited 1×
“The innate immune system is the first line of host defense and the engagement of germline-encoded pattern-recognition receptors (PRRs) activate it in response to harmful stimuli, such as invading pathogens, dead cells, or environmental irritants [1].”
BackgroundCleavage of GSDMD by inflammatory caspases determines pyroptotic cell death
Shi, J., Zhao, Y., Wang, K., Shi, X., Wang, Y., Huang, H., Zhuang, Y., Cai, T., Wang, F., & Shao, F. (2015) · Nature · doi:10.1038/nature15514 · Cited by 6,659
Martinon, F., Burns, K., & Tschopp, J. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00599-3 · Cited by 6,066
A role for mitochondria in nlrp3 inflammasome activation
Zhou, R., Yazdi, A. S., Menu, P., & Tschopp, J. (2011) · Nature · doi:10.1038/nature09663 · Cited by 5,602 · cited 1×
“The role of mitochondrial ROS (mtROS) in NLRP3 inflammasome activation was originally proposed from a study showing that mtROS, as generated by the inhibition of the mitochondrial respiratory chain, can activate the NLRP3 inflammasome [97].”
BackgroundGout-associated uric acid crystals activate the NALP3 inflammasome
Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A., & Tschopp, J. (2006) · Nature · doi:10.1038/nature04516 · Cited by 5,326
Clapham, D. E. (2007) · Cell · doi:10.1016/j.cell.2007.11.028 · Cited by 4,175
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
Duewell, P., Kono, H., Rayner, K. J., Sirois, C. M., Vladimer, G., Bauernfeind, F. G., Abela, G. S., Franchi, L., Nuñez, G., Schnurr, M., et al. (2010) · Nature · doi:10.1038/nature08938 · Cited by 4,026
Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling
Kayagaki, N., Stowe, I. B., Lee, B. L., O’Rourke, K., Anderson, K., Warming, S., Cuellar, T., Haley, B., Roose-Girma, M., Phung, Q. T., et al. (2015) · Nature · doi:10.1038/nature15541 · Cited by 3,686 · cited 1×
“Caspases-4/5/11 induce pyroptosis through the processing of GSDMD, and pannexin-1, which is a protein channel that releases ATP from the cell [17,71,128].”
Background
Research works printed but not linked: 1
- Kang, 2013, Toll-Like Receptor Signaling Licenses IRAK1 For Rapid Activation Of The NLRP3 Inflammasome, J. Immunol. Baltim. Md 1950, 191, 3995
Cited by
Items 201–300 of 1,014
Lipid Oxidation Products on Inflammation-Mediated Hypertension and Atherosclerosis: A Mini Review
Leong, X.-F. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.717740 · Cited by 92
“It was reported that ox-LDL increased the levels of MDA, IL6 and IL-1β in HUVECs (35).”
BackgroundInfluentialLi, J., Wang, H., Liu, D., Li, X., He, L., Pan, J., Shen, Q., & Peng, Y. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.02.001 · Cited by 97
“9 NOD-like receptor 3 (NLRP3) inflammasomes are essential for the maturation of caspase-1, which further leads to the processing and release of the proinflammatory cytokines IL-1β and IL-18 in microglia (Kelley et al., 2019).”
Air pollution and skin diseases: A comprehensive evaluation of the associated mechanism.
Gu, X., Li, Z., & Su, J. (2024) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2024.116429 · Cited by 91
Mediterranean diet and cognitive function: From methodology to mechanisms of action
Siervo, M., Shannon, O. M., Llewellyn, D. J., Stephan, B. C., & Fontana, L. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.09.018 · Cited by 86
Zhou, Y., Zhang, Y.-T. Y., Wang, H., Zhang, X., Chen, Y., & Chen, G. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.109725 · Cited by 93
Pyroptosis in renal inflammation and fibrosis: current knowledge and clinical significance
Liu, Y., Lei, H., Zhang, W., Xing, Q., Liu, R., Wu, S., Liu, Z., Yan, Q., Li, W., Liu, X., et al. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06005-6 · Cited by 100
“Secondly, crystalline agonists, including silica, amyloid, and uric acid crystals, promote lysosomal rupture, which releases lysosomal cathepsins B and L that aid in NLRP3 inflammasome assembly [89].”
BackgroundMei, J., Li, Y., Niu, L., Liang, R., Tang, M., Cai, Q., Xu, J., Zhang, D., Yin, X., Liu, X., et al. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-024-00431-y · Cited by 99
“NOD-like receptor thermal protein domain associated protein 3 (NLRP3) inflammasomes are pivotal in the innate immune system, and their dysregulation contributes to AD [81].”
BackgroundKey Mechanisms and Potential Targets of the NLRP3 Inflammasome in Neurodegenerative Diseases
Guan, Y., & Han, F. (2020) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2020.00037 · Cited by 84
Moya, G. E., Rivera, P. D., & Dittenhafer‐Reed, K. E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22137030 · Cited by 91
El-Fattah, E. E. A., Saber, S., Mourad, A. A. E., El-Ahwany, E. G., Amin, N. A., Cavalu, S. D., Yahya, G., Saad, A. S., Alsharidah, M. S., Shata, A., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112628 · Cited by 92
Proteostasis Disturbances and Inflammation in Neurodegenerative Diseases
Sonninen, T.-M., Goldsteins, G., Laham-Karam, N., Koıstınaho, J., & Lehtonen, Š. (2020) · Cells · doi:10.3390/cells9102183 · Cited by 100
“After priming, several stimuli such as ionic flux, extracellular ATP, ROS, and lysosomal rupture can activate the NLRP3 complex [105].”
BackgroundAnderberg, S. B., Luther, T., Berglund, M., Larsson, R. L., Rubertsson, S., Lipcsey, M., Larsson, A. O., Frithiof, R., & Hultström, M. (2020) · Cytokine · doi:10.1016/j.cyto.2020.155389 · Cited by 98
“Notably, these cytokines clustered the groups perfectly [42,43].”
BackgroundGuo, J. X., Wang, R., & Liu, D. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.639165 · Cited by 97
Lai, W., Zhang, J., Sun, J., Min, T., Bai, Y., He, J., Cao, H., Che, Q., Guo, J., & Su, Z. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.134809 · Cited by 110
Advances in the molecular mechanisms of NLRP3 inflammasome activators and inactivators
Liu, D., Zeng, X., Li, X., Cui, C., Hou, R., Guo, Z., Mehta, J. L., & Wang, X. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.113863 · Cited by 92
Zhang, R. M., McNerney, K. P., Riek, A. E., & Bernal‐Mizrachi, C. (2020) · Acta Physiologica · doi:10.1111/apha.13487 · Cited by 88
Brocker, C. N., Kim, D., Melia, T., Karri, K., Velenosi, T. J., Takahashi, S., Aibara, D., Bonzo, J. A., Levi, M., Waxman, D. J., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19554-7 · Cited by 89
Zhang, C., Huang, Y. L., Ouyang, F., Su, M., Li, W., Chen, J., Xiao, H., Zhou, X., & Liu, B. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02445-7 · Cited by 92
“TLR4/NF-κB signal pathway has been proven to regulate NLRP3 inflammasome activation [12], and we investigated the potential effects of MSC-EVs on TLR4/NF‐κB signal pathway in the SDH of IC rats.”
BackgroundMethodInfluentialMitochondria and sensory processing in inflammatory and neuropathic pain
Ribeiro, P. S. S., Willemen, H. L. D. M., & Eijkelkamp, N. (2022) · Frontiers in Pain Research · doi:10.3389/fpain.2022.1013577 · Cited by 91
Chen, P., Wu, M., He, Y., Jiang, B., & He, M. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01510-8 · Cited by 93
“Treatment with statins abrogated NLRP3 inflammasome assembly and IL-1β secretion.(316,317) Cellular cholesterol levels are mainly monitored in ER membrane by liver X receptor (LXR), Sterol regulatory element binding protein-2 (SREBP2), and erythroid 2 related factor1 (NRF1).”
BackgroundSelf-citationReactive gliosis in traumatic brain injury: a comprehensive review
Amlerova, Z., Chmelová, M., Anděrová, M., & Vargová, L. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1335849 · Cited by 93
Duan, Y., Zhang, L., Angosto-Bazarra, D., Pelegrín, P., Núñez, G., & He, Y. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108405 · Cited by 92
“contribution to the pathogenesis of several inflammatory diseases, including cryopyrinassociated periodic syndromes, Alzheimer’s disease, type 2 diabetes, gout, and atherosclerosis (Kelley et al., 2019; Swanson et al., 2019).”
BackgroundSelf-citationRowaiye, A. B., Okpalefe, O. A., Onuh, O. A., Ogidigo, J. O., Oladipo, O. H., Ogu, A. C., Oli, A. N., Olofinsae, S. A., Onyekwere, O., Abubakar, A. R., et al. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s301784 · Cited by 92
Rostom, B., Karaky, R., Kassab, I., & Veitía, M. S. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.174867 · Cited by 93
Viral-mediated activation and inhibition of programmed cell death
Verburg, S. G., Lelievre, R. M., Westerveld, M. J., Inkol, J. M., Sun, Y. L., & Workenhe, S. T. (2022) · PLoS Pathogens · doi:10.1371/journal.ppat.1010718 · Cited by 92
Shared biological mechanisms of depression and obesity: focus on adipokines and lipokines
Fu, X., Wang, Y., Zhao, F., Cui, R., Xie, W., Liu, Q., & Yang, W. (2023) · Aging · doi:10.18632/aging.204847 · Cited by 124
Yaqinuddin, A., & Kashir, J. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.109906 · Cited by 86
“A diverse array of intracellular mediators have also been implicated in activating the NLRP3 inflammasome [10], and current consensus posits that these mediators induce a common cellular signal [10,13].”
BackgroundBai, R., Lang, Y., Shao, J., Deng, Y., Refuhati, R., & Cui, L. (2021) · ASN NEURO · doi:10.1177/17590914211018100 · Cited by 91
“The NACHT domain has ATPase activity and is considered essential for NLRP3 oligomerisation (Latz et al., 2013; Kelley et al., 2019). c) An N-terminal effector domain consisting of either a CARD, Pyrin or baculoviral inhibitor of apoptosis protein repeat (BIR) domain before the NACHT domain (Ting…”
BackgroundPyroptosis in diabetic nephropathy
Mamun, A. A., Mimi, A. A., Wu, Y., Zaeem, M., Aziz, M. A., Suchi, S. A., Alyafeai, E., Munir, F., & Xiao, J. (2021) · Clinica Chimica Acta · doi:10.1016/j.cca.2021.09.003 · Cited by 90
Particulate matter in COPD pathogenesis: an overview
Kaur, M., Chandel, J., Malik, J., & Naura, A. S. (2022) · Inflammation Research · doi:10.1007/s00011-022-01594-y · Cited by 97
“NLRP3 inflammasome consists of intracellular multimeric protein complexes that activate caspase-1 [102].”
BackgroundLiu, X.-Q., Huang, J., Song, C., Zhang, T., Liu, Y., & Yu, L. S. (2023) · Human & Experimental Toxicology · doi:10.1177/09603271231191436 · Cited by 99
Cao, F., Tian, X.-Y., Li, Z., Lv, Y., Han, J., Zhuang, R., Cheng, B., Gong, Y., Ying, B., Jin, S., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00306 · Cited by 89
“Accumulating evidence has demonstrated that EPO has cytoprotective effects in many pathological diseases, such as cardiac ischemia, kidney ischemia-reperfusion injury, and spinal cord injury (Yang et al., 2003; Lipsic et al., 2006; King et al., 2007).”
BackgroundInhibition of NLRP3 Inflammasome: A Prospective Target for the Treatment of Ischemic Stroke
Feng, Y.-S., Tan, Z., Wang, M., Xing, Y., Dong, F., & Zhang, F. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00155 · Cited by 89
Yi, Y. (2019) · Immunology · doi:10.1111/imm.13134 · Cited by 87
Circadian Control of Inflammasome Pathways: Implications for Circadian Medicine
Pourcet, B., & Duez, H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01630 · Cited by 91
“cells also results in K and Ca2+ fluxes through P2X7 channel opening (23).”
BackgroundInfluentialMacrophage Autophagy and Silicosis: Current Perspective and Latest Insights
Tan, S., & Chen, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22010453 · Cited by 89
“Notably, NALP3 can be activated by silicainduced lysosomal swelling and damage [65,66], suggesting that the important role of NALP3 in AM apoptosis and inflammation of silicosis may correlate with the changes of autophagy-lysosomal system function.”
BackgroundNuclear Receptors in the Control of the NLRP3 Inflammasome Pathway
Duez, H., & Pourcet, B. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.630536 · Cited by 91
Targeting chronic inflammation as a potential adjuvant therapy for osteoporosis
Livshits, G., & Kalinkovich, A. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120847 · Cited by 88
Huang, B., Zhang, N., Qiu, X., Zeng, R., Wang, S., Hua, M., Li, Q., Nan, K., & Lin, S. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.11.021 · Cited by 86
Paniri, A., & Akhavan‐Niaki, H. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118114 · Cited by 88
“The second one is triggered by pathogen associated molecular patterns (PAMPs), and danger-associated molecular patterns (DAMPs) resulting in ASC and pro-caspase-1 assembly, and thereby activation of NLRP3 inflammasome [53,54].”
Fibrosis of Peritoneal Membrane as Target of New Therapies in Peritoneal Dialysis
Masola, V., Bonomini, M., Borrelli, S., Liberato, L. D., Vecchi, L., Onisto, M., Gambaro, G., Palumbo, R., & Arduini, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094831 · Cited by 92
Rajan, S., Tryphena, K. P., Khan, S. S., Vora, L. K., Srivastava, S., Singh, S. B., & Khatri, D. K. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101915 · Cited by 86
Fu, Y., Cao, J., Wei, X., Ge, Y., Su, Z., & Yu, D. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110105 · Cited by 86
Oxidative Stress and Potential Antioxidant Therapies in Vitiligo: A Narrative Review
Białczyk, A., Wełniak, A., Kamińska, B., & Czajkowski, R. (2023) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-023-00672-z · Cited by 96
“An essential element of the NLRP1 inflammasome that activates IL-1 is the protein pyrin domain-containing protein 1 [57, 58].”
BackgroundGao, Z., Sui, J., Fan, R., Qu, W., Dong, X., & Sun, D. (2020) · Drug Design Development and Therapy · doi:10.2147/dddt.s247103 · Cited by 82
Advances in Oral Subunit Vaccine Design
der Weken, H. V., Cox, E., & Devriendt, B. (2020) · Vaccines · doi:10.3390/vaccines9010001 · Cited by 88
Kuwar, R., Rolfe, A., Di, L., Blevins, H., Xu, Y., Sun, X., Bloom, G. S., Zhang, S., & Sun, D. (2021) · Journal of Alzheimer's Disease · doi:10.3233/jad-210400 · Cited by 82
“…domain leucine-rich repeats family protein 3 (NLRP3) inflammasome, the best characterized of all known inflammasomes, can respond to a diverse set of stimuli including reactive oxygen species, mitochondrial damage, ATP and ion flux from injured cells following tissue damage [17, 18].”
InfluentialFerroptosis: an important player in the inflammatory response in diabetic nephropathy
Li, J., Li, L., Zhang, Z., Chen, P., Shu, H., Yang, C., Chu, Y., & Liu, J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1294317 · Cited by 85
Wang, Y., Zhao, Y., Wang, Z., Sun, R., Zou, B., Li, R., Liu, D., Lin, M., Zhou, J., Ning, S., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.652782 · Cited by 80
Pereira, A. C., Pascale, J. D., Resende, R., Cardoso, S., Ferreira, I., Neves, B. M., Carrascal, M. A., Zuzarte, M., Madeira, N. G. G. F., Morais, S., et al. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04211-7 · Cited by 89
“Given that these events are not always implicated in NLRP3 inflammasome activation, the underlying mechanisms are still not fully understood, and more fine-tuned studies are required to decipher the molecular basis of NLRP3 inflammasome activation under specific stressful conditions [25].”
BackgroundSahakyan, G., Véjux, A., & Sahakyan, N. Z. (2022) · Molecules · doi:10.3390/molecules27249035 · Cited by 87
“result, the activation of pro-IL-1β and pro-IL-18 [34,35] (Figure 1).”
BackgroundInfluentialDiabetes and its complications: molecular mechanisms, prevention and treatment
Zhao, L., Yuan, J., Yang, Q., Ma, J., Yang, F., Zou, Y., Liu, K., & Liu, F. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02401-w · Cited by 80
Masrori, P., Beckers, J., Gossye, H., & Damme, P. V. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00525-z · Cited by 87
Age-Related Hearing Loss: The Link between Inflammaging, Immunosenescence, and Gut Dysbiosis
Kociszewska, D., & Vlajkovic, S. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137348 · Cited by 88
Molecular mechanisms and functions of pyroptosis in sepsis and sepsis-associated organ dysfunction
Wen, R., Liu, Y., Tong, X.-X., Zhang, T., & Yang, N. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.962139 · Cited by 86
“Pannexin-1 and P2X7R are associated with K efflux and changes in ATP levels (Kelley et al., 2019).”
BackgroundGSK-3β: An exuberating neuroinflammatory mediator in Parkinson's disease
Khan, S. S., Janrao, S., Srivastava, S., Singh, S. B., Vora, L. K., & Khatri, D. K. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115496 · Cited by 88
Yang, M., Deng, S., Jiang, J., Tian, M., Xiao, L., & Gong, Y. (2023) · Stroke · doi:10.1161/strokeaha.123.043391 · Cited by 83
Wan, P., Zhang, S., Ruan, Z., Liu, X., Yang, G., Jia, Y., Li, Y., Pan, P., Wang, W., Li, G., et al. (2022) · Virulence · doi:10.1080/21505594.2022.2040188 · Cited by 88
“Upon recognizing PAMPs or DAMPs, NLRP3 protein starts oligomerization, subsequently binds ASC and Caspase-1 to assemble into NLRP3 inflammasome platforms, finally facilitating maturation of pro-IL-1β and cell death called pyroptosis [3,11].”
BackgroundcAMP-PKA cascade: An outdated topic for depression?
Gao, F., Yang, S., Wang, J., & Zhu, G. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113030 · Cited by 87
Cui, Y., Yu, H., Bu, Z., Wen, L., Yan, L.-L., & Feng, J. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.894298 · Cited by 85
Jiang, R.-Q., Li, Q., & Sheng, R. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106761 · Cited by 83
Gatlik, E., Mehes, B., Voltz, E., Sommer, U., Tritto, E., Lestini, G., Liu, X., Pal, P., Velinova, M. J., Denney, W. S., et al. (2024) · Clinical and Translational Science · doi:10.1111/cts.13789 · Cited by 83
Wang, X., Ding, B., Liu, W., Qi, L., Li, J., Zheng, X., Song, Y., Li, Q., Wu, J., Zhang, M., et al. (2024) · Journal of the American Chemical Society · doi:10.1021/jacs.4c03478 · Cited by 82
Deng, Y., Zhang, X.-D., Yang, X., Huang, Z., Wei, X., Yang, X.-F., & Liao, W. (2020) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2020.124502 · Cited by 78
Vincristine-induced peripheral neuropathy is driven by canonical NLRP3 activation and IL-1β release
Starobova, H., Monteleone, M. M., Adolphe, C., Batoon, L., Sandrock, C. J., Tay, B., Deuis, J. R., Smith, A. V., Mueller, A., Nadar, E. I., et al. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20201452 · Cited by 81
Involvement of the SIRT1-NLRP3 pathway in the inflammatory response
Chen, H., Deng, J., Gao, H., Song, Y., Zhang, Y., Sun, J., & Zhai, J. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01177-2 · Cited by 85
“However, aberrant activation of the NLRP3 inflammasome has been linked with several inflammatory disorders: cryopyrin-associated periodic syndromes, Alzheimer’s disease, diabetes mellitus, prion diseases, and atherosclerosis [8].”
BackgroundSaber, S., Youssef, M. E., Sharaf, H., Amin, N. A., El-Shedody, R., Aboutouk, F. H., El-Galeel, Y. A., El-Hefnawy, A., Shabaka, D., Khalifa, A., et al. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119123 · Cited by 79
Guo, X., Xu, X., Li, T., Yu, Q., Wang, J., Chen, Y., Ding, S., Zhu, L., Zou, G., & Zhang, X. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.749979 · Cited by 92
“This finding has not been previously reported and is noteworthy as NLRP3 is a key factor necessary for immune defense and the pathogenesis of several inflammatory disorders (20).”
BackgroundMethodInfluentialNunes, P. R., Viana-Mattioli, S., & Sandrim, V. C. (2021) · Cells · doi:10.3390/cells10112828 · Cited by 86
“There are 22 recognized members of the NLR family, between them, NLRP3 (NOD-like receptor family, pyrin domain-containing protein 3) is the most studied and investigated, because this NLR forms complexes with other proteins, forming multimeric complexes, called inflammasomes [42].”
BackgroundThe Role of the Inflammasome in Heart Failure
Wu, J., Dong, E., Zhang, Y., & Xiao, H. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.709703 · Cited by 81
“The detailed mechanism of inflammasome activation has been summarized in recent reviews (Elliott and Sutterwala, 2015; Kelley et al., 2019).”
BackgroundTargeting macrophage TFEB-14-3-3 epsilon Interface by naringenin inhibits abdominal aortic aneurysm
Jia, Y., Zhang, L., Liu, Z., Mao, C., Ma, Z., Li, W., Yu, F., Wang, Y., Huang, Y., Zhang, W., et al. (2022) · Cell Discovery · doi:10.1038/s41421-021-00363-1 · Cited by 80
Pathophysiology of Age-Related Macular Degeneration: Implications for Treatment
Garcia-Garcia, J., Usategui‐Martín, R., Sanabria, M. R., Fernandez-Perez, E., Orriols, J. J. T., & Coco, R. M. (2022) · Ophthalmic Research · doi:10.1159/000524942 · Cited by 85
Kouba, B. R., Camargo, A., Gil‐Mohapel, J., & Rodrigues, A. L. S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137077 · Cited by 84
“Subsequently, different stimuli capable of promoting mitochondrial dysfunction, calcium and potassium ion flux, reactive oxygen species (ROS) production, and lysosomal damage activate the NLRP3 inflammasome, promoting the autoproteolytic activation of pro-caspase-1 [20].”
Busch, M., Bredeck, G., Waag, F., Rahimi, K., Ramachandran, H., Bessel, T., Barcikowski, S., Herrmann, A. P., Rossi, A., & Schins, R. P. F. (2022) · Biomolecules · doi:10.3390/biom12081095 · Cited by 80
“After the successful knockout of the NLRP3 gene, THP-1 cells exhibited virtually no IL-1β release, even after treatment with strong inflammasome activators like LPS [51] or PS-NH2 [52].”
BackgroundLuo, X., Zhao, Y., Luo, Y., Lai, J., Ji, J., Huang, J., Chen, Y., Liu, Z., & Liu, J. (2024) · Clinical and Experimental Nephrology · doi:10.1007/s10157-023-02448-5 · Cited by 82
“Investigations have indicated that NLRP3 inflammasome can be initiated by lipopolysaccharide (LPS), the endotoxin of gram-negative bacteria [12].”
Quagliariello, V., Laurentiis, M. D., Cocco, S., Rea, G., Bonelli, A., Caronna, A., Lombari, M. C., Conforti, G., Berretta, M., Botti, G., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207802 · Cited by 84
“NLRP3 is a new prognostic marker in oncology and acts as a key player in immune-related events involving bacterial and viral infection as well as autoimmune diseases [23,24].”
BackgroundParodi-Rullán, R. M., Javadov, S., & Fossati, S. (2021) · Cells · doi:10.3390/cells10112903 · Cited by 73
“Gasmerdin D forms non-selective pores in the plasma membrane to facilitate the release of cytokines, and thus activates pyroptosis, a form of inflammatory cell death [60,69,70].”
BackgroundInvolvement of Inflammasome Components in Kidney Disease
Aranda‐Rivera, A. K., Srivastava, A., Cruz‐Gregorio, A., Pedraza‐Chaverrí, J., Mulay, S. R., & Scholze, A. (2022) · Antioxidants · doi:10.3390/antiox11020246 · Cited by 79
“The mechanisms involved in non-canonical inflammasome activation signalling via caspase-11 or other effectors, such as caspase-4, caspase-5, and caspase-8, are still incompletely understood [19,23].”
BackgroundTargeting NLRP3-Mediated Neuroinflammation in Alzheimer’s Disease Treatment
Barczuk, J., Siwecka, N., Lusa, W., Rozpędek‐Kamińska, W., Kucharska, E., & Majsterek, I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23168979 · Cited by 80
“Although the mechanisms of its activation are not fully understood [14], many studies have demonstrated that the microglial NLRP3 inflammasome, due to its ability to sense aggregated proteins such as Aβ, alters the generation of interleukin 18 and interleukin 1β (IL-18 and IL-1β, respectively).”
BackgroundThe role of dopamine in NLRP3 inflammasome inhibition: Implications for neurodegenerative diseases
Possemato, E., Barbera, L. L., Nobili, A., Krashia, P., & D’Amelio, M. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101907 · Cited by 78
Klughammer, B., Piali, L., Nica, A., Nagel, S., Bailey, L., Jochum, C., Ignatenko, S., Bläuer, A., Danilin, S., Gulati, P., et al. (2023) · Clinical and Translational Medicine · doi:10.1002/ctm2.1471 · Cited by 83
“15 Aberrant activation of the NLRP3 inflammasome has been implicated in a broad spectrum of inflammatory disorders including atherosclerosis, Alzheimer’s disease, gastrointestinal cancers, and UC.”
BackgroundFusobacterium nucleatum in tumors: from tumorigenesis to tumor metastasis and tumor resistance
Ye, C., Liu, X., Liu, Z., Pan, C., Zhang, X., Zhao, Z., & Sun, H. (2024) · Cancer Biology & Therapy · doi:10.1080/15384047.2024.2306676 · Cited by 80
“55,105 Additionally, the release of OMVs by F. nucleatum promotes the polarization of macrophages toward the pro-inflammatory M1 phenotype.”
BackgroundZhao, X., Wang, Z., Wang, L., Jiang, T., Dong, D., & Sun, M. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107466 · Cited by 88
The Role of the Oral Microbiota in the Etiopathogenesis of Oral Squamous Cell Carcinoma
Vyhnalova, T., Daněk, Z., Gachová, D., & Linhartová, P. B. (2021) · Microorganisms · doi:10.3390/microorganisms9081549 · Cited by 83
“Other proinflammatory cytokines produced as a result of this signaling include TNF-α and IL-18, which are associated with tumor invasiveness, migration, and metastasis [87].”
BackgroundGuo, W., Li, Z., Huang, H., Xu, Z., Chen, Z., Shen, G., Li, Z., Ren, Y., Li, G., & Hu, Y. (2022) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c22804 · Cited by 77
Progress in preclinical studies of macrophage autophagy in the regulation of ALI/ARDS
Liu, C., Xiao, K., & Xie, L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.922702 · Cited by 83
Soraci, L., Gambuzza, M. E., Biscetti, L., Laganà, P., Russo, C. L., Buda, A., Barresi, G., Corsonello, A., Lattanzio, F., Lorello, G., et al. (2022) · Journal of Neurology · doi:10.1007/s00415-022-11491-3 · Cited by 78
“Priming signals are mainly represented by damage-associated molecular patterns (DAMPs) and TLR ligands, as well as IL-1α; activation signals include adenosine triphosphate (ATP), viral DNA, and misfolded proteins [23].”
BackgroundInfluentialSusser, L. I., Nguyen, M.-A., Geoffrion, M., Emerton, C., Ouimet, M. I., Khacho, M., & Rayner, K. J. (2023) · Molecular and Cellular Biology · doi:10.1080/10985549.2023.2253131 · Cited by 81
Khan, M. Z., Huang, B., Kou, X., Chen, Y., Liang, H., Ullah, Q., Khan, I. M., Khan, A. A., Chai, W., & Wang, C. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1290044 · Cited by 78
Moonlighting Proteins: The Case of the Hexokinases
Rodríguez-Saavedra, C., Morgado-Martínez, L. E., Burgos-Palacios, A., King-Díaz, B., López‐Coria, M., & Sánchez‐Nieto, S. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.701975 · Cited by 89
“Most moonlighting proteins were initially described for a welldefined function in a biochemical pathway, like human aconitase (Kennedy et al., 1992) or Trypanosoma cruzi mevalonate kinase (Goldstein and Brown, 1990); or for participating in essential physiological processes, as reactive oxygen…”
BackgroundShukla, P., Mandalla, A., Elrick, M. J., & Venkatesan, A. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2021.628811 · Cited by 78
Yamasaki, A., Okazaki, R., & Harada, T. (2022) · Diagnostics · doi:10.3390/diagnostics12051175 · Cited by 91
“Upon activation of NLRP3 inflammasomes, IL-1β and IL-18 are secreted [95,96].”
BackgroundThe NLRP3 Inflammasome Role in the Pathogenesis of Pregnancy Induced Hypertension and Preeclampsia
Socha, M. W., Malinowski, B., Puk, O., Dubiel, M., & Wiciński, M. (2020) · Cells · doi:10.3390/cells9071642 · Cited by 79
“These findings led to the creation of the NLRP3 crystal-induced activation theory, where MSU, alum, silica, asbestos, β-amyloid, cholesterol crystals, and calcium crystals, induces NLRP3 inflammasome activation [6,45].”
BackgroundAmeliMojarad, M., & AmeliMojarad, M. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14856 · Cited by 73
“136–138 A tetracycline with anti-inflammatory properties that can pass through the BBB is minocycline.”
BackgroundBiological functions of NLRP3 inflammasome: A therapeutic target in inflammatory bowel disease
Song, Y., Zhao, Y., Ma, Y., Wang, Z., Rong, L., Wang, B., & Zhang, N. (2021) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2021.03.003 · Cited by 76
Mannan, A., Garg, N., Singh, T. G., & Kang, H. K. (2021) · Neurochemical Research · doi:10.1007/s11064-021-03402-1 · Cited by 76
IL-1 family cytokines as drivers and inhibitors of trained immunity
Teufel, L. U., Arts, R. J. W., Netea, M. G., Dinarello, C. A., & Joosten, L. A. B. (2021) · Cytokine · doi:10.1016/j.cyto.2021.155773 · Cited by 83
Melchiorri, D., Merlo, S., Micallef, B., Borg, J.-J., & Dráfi, F. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1196413 · Cited by 70
“Biological agents targeting IL-1β mainly include IL1β antibody canakinumab and recombinant IL-1β receptor antagonist anakinra, which share some approved indications.”
BackgroundInfluentialRAGE-TXNIP axis drives inflammation in Alzheimer’s by targeting Aβ to mitochondria in microglia
Sbai, O., Djelloul, M., Auletta, A., Ieraci, A., Vascotto, C., & Perrone, L. (2022) · Cell Death & Disease · doi:10.1038/s41419-022-04758-0 · Cited by 72
“Such activation promotes the secretion of proinflammatory cytokines IL-1β/IL-18 [10] and also the cleavage of Gasdermin D (GSDMD), a key protein of the pyroptosis cascade—a type of cell death triggered by proinflammatory signals [11].”
Oxidative Stress Signaling Mediated Pathogenesis of Diabetic Cardiomyopathy
Tang, Z., Wang, P., Dong, C., Zhang, J., Wang, X., & Pei, H. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/5913374 · Cited by 77
“NLRP3 inflammasome is a multiprotein complex assembled by pattern recognition receptor, which is not critical for the innate immune system but also related to the pathogenesis of several inflammatory diseases including diabetes [47].”
Background
Metadata
- Authors
- Kelley, N., Jeltema, D., Duan, Y., & He, Y.
- Affiliations
- Wayne State University (US)
- Corresponding author
- He, Yuan
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2019-07-06
- Volume
- 20
- Issue
- 13
- Pages
- 3328
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC6651423
- OpenAlex
- W2954782052
- Cited by
- 3,539
- References
- 176
- Citations by year
- 2026: 466 · 2025: 573 · 2024: 631 · 2023: 687 · 2022: 563 · 2021: 383 · 2020: 220 · 2019: 12
- FWCI
- 25.94
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Wayne State University
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases (K22AI120988)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › IL-33, ST2, and ILC Pathways
- Keywords
- NLRP3 inflammasome, inflammasome activation, caspase-1, IL-1β, IL-18, innate immunity, cryopyrin-associated periodic syndromes, Alzheimer's disease, diabetes mellitus, atherosclerosis, ion flux, mitochondrial dysfunction, reactive oxygen species, lysosomal damage, post-translational modification, inflammasome regulation
- MeSH terms
- NLR Family, Pyrin Domain-Containing 3 Protein, Animals, Humans, Mitochondria, Models, Biological, Protein Processing, Post-Translational, Reactive Oxygen Species, Inflammasomes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.